摘要
目的探讨兰索拉唑联用达喜（铝碳酸镁）治疗胃溃疡临床的疗效。方法选自我院门诊198例胃溃疡的患者，分为治疗组105例，对照组93组，两组根除幽门螺杆菌（H．Pylori）三联治疗方法。1周后，治疗组用兰索拉唑和达喜治疗；对照只用兰索拉唑。1疗程为8周。结果治疗组的痊愈率和总有效率分别为61．91％和93．33％；对照组的痊愈率和总有效率分别为40．09％和80．65％，两组的痊愈率和总有效率比较差异有统计学意义俨〈0．05）。药物未见明显不良反应。结论兰索拉唑联用达喜治疗胃溃疡，疗效较单用兰索拉唑显著。
Objective To investigate the clinical efficacy of treating gastric ulcer with hydrotalcite and lansoprazole. Methods 198 patients with gastric ulcer were randomly divided into treatment group （n=105） and control group （n=93）, Two groups underwent firstly the eradication of helicobacter pylori and eradication triple therapy. From the second week, patients in the treatment group were treated with lansoprazole combined with hydrotalcite while patients in the control group were treated with lansoprazole only. The therapeutic course was 8 weeks. Results The cured rate and the total effective rate in treatment group were 61.91% and 93.33% VS 33.33% and 74.19% in the control group .The differences were statistically significant between the two groups （P〈0.05）. No obvious side effects occurred. Conclusion Treating gastric ulcer with lansoprazole and hydrotalcite has better effect than that with lansoprazole only.
出处
《国际医药卫生导报》
2013年第8期1135-1137,共3页
International Medicine and Health Guidance News
关键词
兰索拉唑
达喜
胃溃疡
Lansoprazole
Hydrotalcite
Gastric ulcer
